AI / data analytics / healthtech / informatics

#AI / data analytics / healthtech / informatics #Automation / robotics #Business #Cell therapy #Chemical engineering #Chemistry #Combinatorial chemistry #Drug development #Drug discovery #Gene therapy #Genomics #High throughput screening #Lead discovery #Lead optimisation #Oncology #Protein chemistry / Proteomics #RNA #Screening

Drug Delivery – Adding value to drug development and commercialisation

Drug Delivery - Adding value to drug development and commercialisation By Dr Cornelis 'Cees' Winnips The importance of drug delivery as a tool to improve R&D productivity, to provide a pathway for valuable drugs to be successfully commercialised and as an expanding resource to the pharmaceutical and biotech industry, has… Read More

#Archive

#Academic #AI / data analytics / healthtech / informatics #Analysis #Biomarkers #Business #Chemistry #Combinatorial chemistry #Drug development #Drug discovery #Genetics / genomes #Genetics / genomics #Genomics #Lead discovery #Microbiology #RNA #Sequencing

Do venture capitalists act as gatekeepers of new technology?

Do venture capitalists act as gatekeepers of new technology? By Dr June Grindley and Samantha Smart This article discusses the important role that venture capitalists and others play in helping to create companies around new technologies. We asked a number of venture capitalists, when considering funding a new company, what… Read More

#Archive

#Academic #AI / data analytics / healthtech / informatics #Analysis #Analytical chemistry #Animal models #Assay development & optimisation #Chemistry #Clinical trials #Combinatorial chemistry #Computational chemistry #Drug development #Drug discovery #Drug targets #Genetics / genomes #Genetics / genomics #Genomics #High Content Screening #High throughput screening #In Silico Biology #Lead discovery #Microbiology #Molecular medicine #Screening #Sequencing #Stem cells #System biology #Systems biology #Translational #Translational chemistry

The Industrialisation of Bioinformatics

The Industrialisation of Bioinformatics By Dr Alex Titomirov With the completion of the ‘draft’ sequence of the human genome predicting an estimate of 40,000-120,000 genes that describe us, the real work begins. The problem now is not lack of data but lack of tools to thoroughly analyse what we already… Read More

#Archive

#AI / data analytics / healthtech / informatics #Analysis #Animal models #Assay development & optimisation #Assay development optimisation & technology #Automation / robotics #Biochemistry #Biomarkers #Business #Cellular & Molecular biology #Cellular assays #Chemical engineering #Chemistry #Clinical specialities #Clinical trials #Combinatorial chemistry #Computational chemistry #Drug development #Drug discovery #Drug targets #Genetics / genomes #Genomics #High Content Screening #High throughput screening #In Silico Biology #Lead discovery #Lead optimisation #Medicinal chemistry #Molecular medicine #PCR #Preclinical #Protein chemistry / Proteomics #RNA #Screening #Sequencing #Stem cells #System biology #Systems biology #Target validation

Exploiting the fruits of the human genome – A strategic perspective

By Dr David C. U’Prichard It is almost axiomatic that the pharmaceutical R&D industry has not achieved in the last decade an increase in productivity (measured as high value NCEs) commensurate with the explosion of new biological information, chemistry techniques and information storage/retrieval/examination systems, let alone the real increase in… Read More

#Archive

Scientist in laboratory
#Academic #AI / data analytics / healthtech / informatics #Analysis #Automation / robotics #Chemistry #Clinical specialities #Combinatorial chemistry #Computational chemistry #Drug development #Drug discovery #Gene editing #High throughput screening #Immunology #Lead discovery #Lead optimisation #Medicinal chemistry #Organic chemistry #Preclinical #RNA #Screening #Toxicology

Web-based Cheminformatics for Bench Chemists

By Peter Ertl, Wolfgang Miltz, Bernhard Rohde and Paul Selzer Readily accessible tools with easy to use interfaces, especially integrated into regularly used desktop applications, can improve the impact of cheminformatics in pharmacological research. Starting either from a single molecule or from a larger data set, these tools provide information… Read More

#Archive

Genome editing
#AI / data analytics / healthtech / informatics #Assay development optimisation & technology #Cellular & Molecular biology #Clinical trials #Drug development #Drug discovery #Genetics / genomes #Genetics / genomics #Genomics #Lead discovery #Molecular medicine #Preclinical #RNA #Sequencing #System biology #Systems biology #Toxicology

The role of toxicogenomics in drug discovery

The role of toxicogenomics in drug discovery By Dr Robin E. Neft and Dr Spencer Farr The information that toxicogenomics can bring in terms of toxic mechanisms, safety and efficacy must ultimately have a major impact on the drug discovery process. Large scale genome sequencing has lead to elucidation of… Read More

#Archive

#AI / data analytics / healthtech / informatics #Analysis #Assay development optimisation & technology #Automation / robotics #Biochemistry #Biomarkers #Cellular & Molecular biology #Cellular assays #Chemical engineering #Chemistry #Clinical specialities #Drug development #Drug discovery #Drug targets #Enabling technologies #Genetics / genomes #Genomics #High throughput screening #Imaging #Lead discovery #Mass spectrometry / NMR #Pharmacology #Preclinical #Protein chemistry / Proteomics #Screening #Sequencing #Stem cells #Target validation #Translational #Translational chemistry

Proteomics – From a drug discovery perspective

By Dr Ashok R. Dongre and Dr Stanley A. Hefta The genomic sequencing efforts spawned the field of proteomics by providing the basic blueprint for protein sequences, enabling proteomics to become the contemporary technology for studying the underlying mechanisms of disease. This review will address the technologies related to proteomic… Read More

#Archive

#AI / data analytics / healthtech / informatics #Analysis #Assay development optimisation & technology #Automation / robotics #Business #Cellular assays #Chemical engineering #Clinical trials #Drug development #Drug discovery #Drug targets #Genomics #Lead discovery #Molecular medicine #Nanomedicine / nanotechnology #Pharmacogenomics #Pharmokinetics #Preclinical #Protein chemistry / Proteomics #RNA #Screening #Toxicology

Harnessing the CRO Intellect

Harnessing the CRO Intellect By Ian Lennox and Dr Nigel Brown There is no question that pharmaceutical companies are qualified to perform their own discovery and preclinical research. However, to fully exploit the new technologies in the early research phases, to maximise drug leads, and to minimise costs, would the… Read More

#Archive

Close up of vaccine syringe
#AI / data analytics / healthtech / informatics #Animal models #Cell / tissue culture #Cell culture #Cell therapy #Cellular & Molecular biology #Clinical trials #Gene therapy #Genetics / genomes #Immunology #Immunology / Virology & Vaccines #Oncology #Pharmacology #Preclinical #Protein chemistry / Proteomics #RNA #Stem cells

Emerging therapeutic vaccines

Emerging therapeutic vaccines By Marc Hertz, Soren Mouritsen and Anand Gautam The excitement over the past 30 years for immunotherapy of cancer and other diseases has not led to the expected clinical successes. Over-enthusiasts predicted a cure for cancer with the initial development of monoclonal antibody technology, and later the… Read More

#Archive

#AI / data analytics / healthtech / informatics #Analysis #Analytical chemistry #Automation / robotics #Business #Cellular & Molecular biology #Chemical engineering #Chemistry #Combinatorial chemistry #Drug development #Drug discovery #Drug targets #High throughput screening #Lead discovery #Lead optimisation #Mass spectrometry / NMR #Medicinal chemistry #RNA #Screening #Target validation

Recent Developments in Combinatorial Chemistry

Recent Developments in Combinatorial Chemistry By Dr Anthony D Baxter Combinatorial chemistry has advanced significantly from the early 1990s when it was a new science of mainly conceptual interest to today where it has evolved into a key component of the drug discovery industry. The needs of the Pharma industry… Read More

#Archive

High-throughput screening
#ADME / Tox #AI / data analytics / healthtech / informatics #Analysis #Analytical chemistry #Assay development & optimisation #Assay development optimisation & technology #Automation / robotics #Biochemistry #Business #Cellular & Molecular biology #Cellular assays #Chemistry #Combinatorial chemistry #Computational chemistry #Drug development #Drug discovery #Drug targets #Genomics #High Content Screening #High throughput screening #Imaging #Isotope labelling #Lead discovery #Lead optimisation #PCR #Pharmacology #Protein chemistry / Proteomics #RNA #Screening #Stem cells #Toxicology

HTS a strategy for drug discovery

HTS a strategy for drug discovery By Dr AR Knight, Cerebrus Ltd Whichever technologies are implemented, high throughput screening is set to become one of the cornerstones of drug discovery, however deciding which strategy to implement will provide many headaches. This article concentrates on screens identifying the interaction of small… Read More

#Archive

#Academic #AI / data analytics / healthtech / informatics #Analysis #Analytical chemistry #Business #Chemistry #Clinical specialities #Clinical trials #Computational chemistry #Drug development #Drug discovery #Drug targets #Gene therapy #Genomics #In Silico Biology #Lead discovery #Regulatory #RNA #Therapeutics

Target discovery and drug design: extracting the value from genomics

By Professor Ken Powell, Deputy Director, Wolfson Institute for Biomedical Research Pharmaceutical research and development is changing. The old model of drug discovery, based on a combination of imprecise candidate generation and broad physiological screens, has given way to more specific and intelligent approaches to target identification and drug design. Read More

#Archive

#AI / data analytics / healthtech / informatics #Automation / robotics #Business #Chemical engineering #Clinical specialities #Clinical trials #Drug development #Drug discovery #Enabling technologies #Genomics #High Content Screening #Lead discovery #Protein chemistry / Proteomics #RNA

The Future Role of CROs

The Future Role of CROs By John M Hall PhD and Ludo Reynders PhD The increasing reliance by big pharmaceutical companies on CROs presents a mixture of challenges and opportunities for the industry. Given that the majority of customers are global in their reach, the CRO industry must be prepared… Read More

#Archive

#AI / data analytics / healthtech / informatics #Analysis #Assay development optimisation & technology #Biochemistry #Business #Cellular & Molecular biology #Cellular assays #Drug development #Drug discovery #Drug targets #Genetics / genomes #Genomics #High Content Screening #High throughput screening #Immunology #Lead discovery #Mass spectrometry / NMR #Protein chemistry / Proteomics #RNA #Screening #Sequencing #Stem cells #Target validation #Translational #Translational chemistry #Urinary

Gene function via the analysis of multi-pro

By Matthias Mann, Protein Interaction Laboratory (PIL), University of Southern Denmark Affinity proteomic methods can translate genomic data into validated targets for drug discovery. Baits such as tagged gene product or small molecules obtained from cell-based assays are used to purify interacting proteins. These proteins are then identified by high… Read More

#Archive

#Academic #AI / data analytics / healthtech / informatics #Analysis #Assay development optimisation & technology #Automation / robotics #Business #Cellular assays #Chemistry #Clinical trials #Drug development #Drug discovery #Drug targets #Enabling technologies #Genetics / genomes #Genetics / genomics #Genomics #High Content Screening #Lead discovery #PCR #RNA #Sequencing #Stem cells #Toxicology

Using Expression Databases for Drug Discovery

Using Expression Databases for Drug Discovery By Dr Greg Lennon Reference databases are being built cataloguing the amount of RNA each gene makes under different conditions and in different individuals. These databases can be mined easily and effectively to aid the drug discovery process. The success of the Human Genome… Read More

#Archive